久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Adamis Provides Update on Zimhi drugs
    June 21, 2021
    Adamis Pharmaceuticals Corporation today announced that the FDA has accepted for review the Company’s resubmitted New Drug Application (NDA) for ZIMHI?, which is its higher naloxone injection product candidate for the treatment of opioid overdose.
PharmaSources Customer Service